A New Dawn in Chronic Urticaria:

Opportunities to Improve Patient Outcomes with Modern Diagnostic Principles and Innovative Treatments on the Horizon


This Learning Center is a freely accessible educational platform for dermatologists, allergists, family practice/general practice physicians, internal medicine physicians, pediatricians, nurse practitioners, physician assistants, and other clinicians who may be involved in the identification and management of patients with chronic urticaria (CU). Our goal is to ensure that you – the practicing clinician – have access to the most accurate, up-to-date information for the management of these patients.


Recognizing and Diagnosing Chronic Urticaria in Practice: How Well Do You Know Current Guidelines?

Credit Available: 0.5 AMA PRA Category 1 credit(s)™

In this activity, expert Jonathan A. Bernstein, MD, will provide learners with a comprehensive understanding of CU, covering the latest epidemiological data, natural history, and prognosis, as well as the major classifications and subtypes of CU and their associated clinical manifestations. Dr. Bernstein also will review current guideline recommendations for the evaluation and diagnosis of CU, highlighting region-specific considerations. Practical strategies for recognizing and diagnosing CU, including tips for differential diagnosis and severity assessment, will be presented. To enhance the learning experience, case vignettes will be used to illustrate how these strategies can be applied in real-world clinical scenarios.

Recent Updates on the Immunological Processes that Contribute to the Burden of Chronic Urticaria: What Do Healthcare Providers Need to Know?

Credit Available: 0.5 AMA PRA Category 1 credit(s)™

In this activity, expert Marta Ferrer, MD, PhD, will provide learners with a holistic understanding of the burden of CU and the importance of effective treatment in optimizing patient outcomes and quality of life. Dr. Ferrer will then delve into the pathophysiology of CU, covering both mast cell–dependent and –independent pathways, and discussing recent research findings on novel therapeutic targets, including mediators, receptors, and signaling pathways of immune cells implicated in the disease. By the end of this activity, learners will have a comprehensive understanding of the latest research informing the pathophysiology of CU and the potential for novel therapeutic interventions.

Fulfilling an Unmet Need in Treating Chronic Urticaria: How Might New and Emerging Approaches Fit into the Paradigm?

Credit Available: 0.5 AMA PRA Category 1 credit(s)™

In this activity, expert Emek Kocatürk Göncü, MD, will explore the current state of management of patients with CU. Through the use of case vignettes, learners will gain insight into the comprehensive needs of patients with CU and challenges in their treatment. Dr. Göncü will also discuss current guidelines and recommendations for stepwise management, highlighting key differences and similarities between international guidelines. Emerging therapies for CU also will be discussed, including their mechanisms of action, available clinical evidence, and profiles of ongoing clinical trials. Learners will gain a deeper understanding of the potential place of these therapies within individualized care plans and how they may fulfill unmet needs in CU treatment.